PathoGenetix, Inc. (formerly U.S. Genomics) is developing an automated system for identification and strain typing of pathogens in a broad range of complex sample types. Unlike approaches that require specific reagents for detection of each pathogen, PathoGenetix' approach uses a single reagent set to create genomic barcodes which are then used to detect and identify thousands of strains from hundreds of species.
Employees: 11-50
Total raised: $21.5M
Investors 1
| Date | Name | Website |
| - | Ascension ... | ascensionv... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.10.2013 | Series C | $10M | - |
| 01.11.2011 | Series B | $7.5M | - |
| 01.08.2011 | Series B | $4M | - |
Mentions in press and media 9
| Date | Title | Description |
| 18.11.2013 | Report Shows Investors Setting Bar Higher for Digital Health Funding | Digital health funding for October 2013 reached $131 million compared to October 2012 at $85 million, according to the latest October 2013 StartUp Health Insights Funding report. With only a total of 31 deals this past month, the market is ... |
| 30.10.2013 | PathoGenetix Announces $10 Million Series C Financing | - |
| 30.10.2013 | PathoGenetix Announces $10M Series C | WOBURN, MA, Commercial-stage developer of an automated system for rapid bacterial identification, announced today that it has secured $10 million in a Series C financing. >> Click here for more funding data on PathoGenetix >>... |
| 30.10.2013 | PathoGenetix Raises $10M in Series C Financing | PathoGenetix, a Woburn, MA-based provider of rapid bacterial identification solutions, raised $10m in Series C financing. Backers included Ascension Health Ventures, Excel Venture Management and Health Care Ventures. The company intends to ... |
| 01.11.2011 | PathoGenetix Raises $7.5M in Second Closing of Series B Financing | PathoGenetix Inc., a Woburn, Massachusetts-based developer of an automated system for the identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology, has raised $7.5m in the second closing of its Se... |
| 01.11.2011 | PathoGenetix Secures $7.5M Series B | Company developing Genome Sequence Scanning technology raised funds from new investor Ascension Health Ventures (AHV) along with the existing investor group: Excel Venture Management, CB Health Ventures, and HealthCare Ventures. >>... |
| 01.08.2011 | PathoGenetiX Raises $4.0M in First Closing of $9.5M Series B Financing | PathoGenetiX Inc., a Woburn, Massachusetts-based developer of an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology, has raised $4.0m in the first closing of i... |
| 01.08.2011 | Pathogenetix Nabs $4M | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Pathogenetix, a Woburn, MA-based company formerly named U.S. Genomics, has raised $4 million of an equity offering that could total $9.5 million, an SEC filing shows. Last Nov... |
| 01.08.2011 | PathoGenetiX Completes $4M Series B | Funds to complete development of first commercial Genome Sequence Scanning-Based Systems. >> Click here for more funding data on PathoGenetiX >> To export PathoGenetiX funding data to PDF and Excel, click here WOBURN, MA,... |